Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Apr 01, 2024

SELL
$28.82 - $77.35 $150,555 - $404,076
-5,224 Closed
0 $0
Q3 2021

Apr 01, 2024

BUY
$98.77 - $132.17 $12,445 - $16,653
126 Added 2.47%
5,224 $653 Million
Q1 2021

Apr 01, 2024

BUY
$127.04 - $179.1 $647,649 - $913,051
5,098 New
5,098 $778 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.